Search research articles
Contact Us
Filters
Showing results (61-70 of 188) with videos related to
Page
of 19
Sort By:
Breast Cancer Research and Treatment
|
November 29, 2017
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J Press, Abiola Ibraheem, M Eileen Dolan, et al.
DNA Repair
|
May 9, 2007
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals
Ryan J Hansen, Susan M Ludeman, Sari J Paikoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2018
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
Matthew R Trendowski, Omar El Charif, Paul C Dinh, et al.
Pharmacogenetics
|
July 2, 2003
Characterization of multiple promoters in the human carboxylesterase 2 gene
Michael H Wu, Peixian Chen, Benjamin F Remo, et al.
Frontiers in Pharmacology
|
September 11, 2025
Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population
Mohammad Shahbazi, Heather E Wheeler, Xindi Zhang, et al.
The Pharmacogenomics Journal
|
May 26, 2018
Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity
Ruowang Li, Dokyoon Kim, Heather E Wheeler, et al.
Scientific Reports
|
November 14, 2024
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
Mohammad Shahbazi, Heather E Wheeler, Gregory T Armstrong, et al.
Cancer Chemotherapy and Pharmacology
|
November 11, 2008
Role of copper transporters in resistance to platinating agents
Cara A Rabik, Edward B Maryon, Kristen Kasza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma
Thomas F Gajewski, Jeffrey Sosman, Stanton L Gerson, et al.
Clinical Pharmacology and Therapeutics
|
March 4, 2025
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information
Loren Saulsberry, Jacob C Jameson, Robert D Gibbons, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 188) with videos related to
Sort By:
Page
of 19
Breast Cancer Research and Treatment
|
November 29, 2017
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J Press, Abiola Ibraheem, M Eileen Dolan, et al.
DNA Repair
|
May 9, 2007
Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals
Ryan J Hansen, Susan M Ludeman, Sari J Paikoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2018
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
Matthew R Trendowski, Omar El Charif, Paul C Dinh, et al.
Pharmacogenetics
|
July 2, 2003
Characterization of multiple promoters in the human carboxylesterase 2 gene
Michael H Wu, Peixian Chen, Benjamin F Remo, et al.
Frontiers in Pharmacology
|
September 11, 2025
Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population
Mohammad Shahbazi, Heather E Wheeler, Xindi Zhang, et al.
The Pharmacogenomics Journal
|
May 26, 2018
Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity
Ruowang Li, Dokyoon Kim, Heather E Wheeler, et al.
Scientific Reports
|
November 14, 2024
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
Mohammad Shahbazi, Heather E Wheeler, Gregory T Armstrong, et al.
Cancer Chemotherapy and Pharmacology
|
November 11, 2008
Role of copper transporters in resistance to platinating agents
Cara A Rabik, Edward B Maryon, Kristen Kasza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma
Thomas F Gajewski, Jeffrey Sosman, Stanton L Gerson, et al.
Clinical Pharmacology and Therapeutics
|
March 4, 2025
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information
Loren Saulsberry, Jacob C Jameson, Robert D Gibbons, et al.
Page
of 19